The invention provides bacillus subtilis strains NCIB 12375, NCIB 12376 and NCIB 12616, which have improved antimicrobial activity. The invention also relates to the use of such strains in the control of microbial infections and microbial contamination.

Patent
   5344647
Priority
Jan 21 1987
Filed
Dec 29 1992
Issued
Sep 06 1994
Expiry
Sep 06 2011

TERM.DISCL.
Assg.orig
Entity
Large
19
9
all paid
3. A biologically pure culture o bacillus subtilis strain R1, a sample of which has been deposited at the National Collections of Industrial Bacteria Ltd. (NCIB) on 24 December 1987 under the accession number NCIB 12616 or a mutant thereof having the same antimicrobial activity as the said strain.
1. A biologically pure culture of bacillus subtilis, Strain JB 3, a sample of which has been deposited at the National Collections of Industrial Bacteria Ltd. (NCIB) on 22 December 1986 under accession number NCIB 12375, or a mutant thereof having the same antimicrobial activity as the said strain.
2. A biologically pure culture of bacillus subtilis strain JB 3.6, a sample of which has been deposited at the National Collections of Industrial Bacteria Ltd. (NCIB) on 22 December 1986 under accession number NCIB 12376, or a mutant thereof having the same antimicrobial activity as the said strain.
4. An antimicrobial composition comprising a biologically pure culture of bacillus subtilis strain JB 3, or JB 3.6, or R1, or a mutant of any of such strains, said mutant having the same antimicrobial activity as the said strain, or antimicrobial material isolated from any of such strains, together with a carrier or diluent therefor.
5. The antimicrobial composition according to claim 4, comprising a biologically pure culture of bacillus subtilis strain JB 3, or a mutant thereof having the same antimicrobial activity as the said strain, or said antimicrobial material isolated from such strain.
6. The antimicrobial composition according to claim 4, comprising a biologically pure culture of bacillus subtilis strain JB 3.6, or a mutant thereof having the same antimicrobial activity as the said strain, or said antimicrobial material isolated from such strain.
7. The antimicrobial composition according to claim 4, comprising a biologically pure culture of bacillus subtilis strain R1, or a mutant thereof having the same antimicrobial activity as the said strain, or said antimicrobial material isolated from such strain.
8. A method of controlling microbial infections in plants, which comprises applying to the plants or their environment bacillus subtilis strain JB 3, or JB 3.6, or R1, or a mutant of any of such strains, said mutant having the same antimicrobial activity as the said strain, or an antimicrobial composition according to claim 4.
9. The method of claim 4, comprising applying to said plants or their environment bacillus subtilis strain JB 3, or a mutant thereof having the same antimicrobial activity as the said strain, or said antimicrobial material isolated from such strain.
10. The method of claim 8, comprising applying to said plants or their environment bacillus subtilis strain JB 3.6, or a mutant thereof having the same antimicrobial activity as the said strain, or said antimicrobial material isolated from such strain.
11. The method of claim 8, comprising applying to said plants or their environment bacillus subtilis strain R1, or a mutant thereof having the same antimicrobial activity as the said strain, or said antimicrobial material isolated from such strain.
12. The biologically pure culture of bacillus subtilis according to claim 1, which is in a form suitable for use in control of microbial infection or microbial contamination.
13. The biologically pure culture of bacillus subtilis according to claim 2, which is in a form suitable for use in control of microbial infection or microbial contamination.
14. The biologically pure culture of bacillus subtilis according to claim 3, which is in a form suitable for use in control of microbial infection or microbial contamination.
15. The antimicrobial composition according to claim 4, also including a gum or surfactant.
16. The antimicrobial composition according to claim 15, which is in a form suitable for use in control of microbial infection or microbial contamination.
17. The antimicrobial composition according to claim 4, which is in a form suitable for use in control of microbial infection or microbial contamination.
18. The method of claim 8, wherein said antimicrobial composition further comprises a gum or surfactant.
19. The method of claim 9, wherein said antimicrobial composition further comprises a gum or surfactant.
20. The method of claim 10, wherein said antimicrobial composition further comprises a gum or surfactant.
21. The method of claim 11, wherein said antimicrobial composition further comprises a gum or surfactant.

This application is a continuation of application Ser. No. 07/144,174, filed on Jan. 15, 1988, now abandoned.

This invention relates to a strain of Bacillus subtilis having antimicrobial activity.

Bacillus subtilis is a spore-forming, aerobic, highly resilient, flagellated bacterium. It has been the subject of a great deal of biological control research and promising results have been reported in various trials on, for example Rhizoctonia and Pythium damping off (Olsen 1964, Olsen and Baker 1968, Broadbent et al 1971), Nectria galligena infection of leaf scars on apple trees (Swinburne 1973), Fusarium seedling blight in wheat (Chang and Kommedahl 1968). B. subtilis also has the advantage of being easy and cheap to produce, requiring only simple growth media.

We have isolated a new strain of B. subtilis during screening of bacteria from the leaf surface of faba bean plants grown in field plots at Sutton Bonington. The new strain has been found to have surprising antimicrobial activity on various bioassays.

The invention thus provides Bacillus subtilis strain (JB 3), a sample of which has been deposited on 22 December 1986 at The National Collections of Industrial Bacteria Ltd (NCIB), Tory Research Station, P.O. Box 31, 135 Abbey Road, AB9 8DG, Scotland, under accession number NCIB 12375, or a mutant or derivative thereof having antimicrobial activity.

A particularly effective mutant or derivative of strain JB 3 is strain JB 3.6, a sample of which has been deposited on 22 December 1986 at NCIB under accession number NCIB 12376.

Another particularly effective mutant or derivative of strain JB 3 is strain R1, a sample of which has been deposited on 24 December 1987 at NCIB under accession number NCIB 12616.

The invention also relates to the use of the above strains or derivatives or mutants thereof, or antimicrobial materials derived from these strains or derivatives or mutants thereof, in controlling plant diseases, microbial infections of animals and humans and in controlling microbial contamination generally. The new strains can optionally be used in mixtures with other microbial strains.

The new strains are particularly useful in controlling plant fungal diseases. For application to plants, the strains may be formulated into compositions containing suitable carriers or diluents. In order to ensure wettability of plant leaves during application, the compositions may contain gums or surfactants.

In in-vitro bioassays the new strain was found to have antifungal activity against a wide range of fungal pathogens, causing marked distortion of germ tubes, lysis of the hyphal tips and subsequent death of the fungi. Fungi tested so far include:

Alternaria spp.

Botrytis spp.

Leptosphaeria spp.

Rhizoctonia spp.

Sclerotinia spp.

Ascochyta spp.

Candida spp.

Experiments with whole plants have demonstrated control of rust infections (e.g. Puccinia spp.)

Antibacterial activity was found in in-vitro tests against organisms such as:

Staphylococcus spp.

Streptococcus spp.

In glasshouse tests with intact faba bean and barley plants, spraying with a suspension of the B. subtilis strain effectively prevented the development of symptoms when the leaves were subsequently inoculated with Botrytis fabae or Puccinia hordei respectively.

The antimicrobial activity is produced under nutrient-limiting conditions which are commonly associated with the process of sporulation. It is anticipated that wetting and drying cycles on the leaf surface would result in cycles of germination and sporulation of B. subtilis and consequent production of antimicrobial activity. Unlike some antimicrobial activities of B. subtilis, the new activity is very stable, remaining active even after autoclaving.

Much antimicrobial activity is merely produced as an artefact of axenic culture on synthetic media. However, it is highly likely that this activity is actually produced on leaf surfaces. Young cultures of the bacterium (12 - 18 h) which showed no detectable antimicrobial activity provided effective disease control when applied to infected leaves. On microscopic examination the pathogens showed identical distorted growth to that observed in vitro.

The following characteristics of the new strain were noted:

______________________________________
Tests at 30°C
Spore shape: Elliptical or
(Maximum growth
cylindrical temp 50°C)
______________________________________
Sporangium distended
-
distinctly:
Spore position dominant:
Central
Rod width, μm
1
Intracellular globules
-
(a)
Anaerobic growth (a)
(+)
(weakly positive)
Growth in 5% NaCl
+
Growth in 7% NaCl
+
Growth in pH 5.7 broth
+
Acid from glucose (b)
+
Gas from glucose (b)
-
VP (acetoin) +
Egg Yolk agar opacity
-
Casein decomposition
+
Gelatin decomposition
+
Starch hydrolysis
+
NO3- to NO2-
+
Aesculin hydrolysis
+
Citrate, Koser's
+
Arginine dihydrolase
-
Moller's
pH in VP broth
5.2
______________________________________
(a) on glucose agar
(b) peptone water sugar, Andrade's indicator

Acid was produced from the following carbon sources at 30°C:

Glycerol, L-arabinose, ribose, D-xylose, galactose, D-glucose, D-fructose, D-mannose, inositol, mannitol, sorbitol, α-methyl-D-glucoside, N-acetyl glucosamine, amygdalin, arbutin, salicin, cellobiose, maltose, lactose, melibiose, sucrose, trehalose, inulin, D-raffinose, starch, glycogen, β-gentiobiose, D-turanose.

The invention is illustrated by the following Examples, and by the accompanying drawing showing the results of Example 4B.

PAC Isolation of the novel strain

The bacterium was isolated from plots of faba bean grown at the Nottingham University School of Agriculture at Sutton Bonnington.

Preliminary experiments indicated considerable variation on the development of chocolate spot disease (Botrytis fabae) on leaves removed from field plots. This may have been a reflection of differences in the leaf surface microflora. Isolations of potential antagonists of plant pathogens were therefore made from leaves shown to permit only limited disease development.

Bifoliate leaves were detached and one leaflet of each pair was inoculated with Botrytis cinerea and Botrytis fabae. After 24h incubation microorganisms were isolated from the leaflets opposite those with low disease scores and tested for antifungal activity. Repeated isolations were made after shaking 2-3 leaflets in 50 ml aliquots of sterile distilled water for 30 minutes. Bacteria were isolated by plating out washings onto nutrient agar containing nystatin to suppress fungal growth. After 48-72 h incubation, cells from individual colonies were streaked onto one side of plates of V8 juice agar and grown at 30°C for 3 days. The opposite side of the agar was inoculated with a plug of Botrytis cinerea and following incubation antimicrobial activity was indicated by a zone of inhibition of fungal growth compared to controls. Such antimicrobial activity was associated with several colonies of one bacterial species subsequently identified as Bacillus subtilis. One of these colonies was designated as JB 3.

Serial dilutions of the bacterial cells derived from pure cultures of JB 3 were plated onto nutrient agar. Plates with 1-50 discrete colonies were selected for isolation of single-cell cultures. A total of 22 such isolates were made and tested for antimicrobial activity. Point inoculation of plates of V8 agar seeded with conidia of Botrytis cinerea were made from individual colonies. After 72h incubation zones of inhibition of fungal growth were measured. One isolate (designated JB3.6) produced an inhibitory zone much larger than any other isolate tested and this was used extensively in subsequent tests.

PAC In vitro Anti-Fungal Bioassays

Simultaneous inoculations of B. subtilis strain JB 3.6 and the test fungus were made onto potato dextrose agar plates. Two B. subtilis streaks, 1 cm long, were made 1 cm from diametrically opposite sides of each plate. A 0.5 cm mycelial plug of the test fungus was placed in the middle. Control plates had no B. subtilis inoculation. Plates were incubated at 25° C. for up to 12 days. The diameter of each fungal colony, on a line through the centre of the mycelial plug at right angles to the streaks of B. subtilis, was measured daily. Percentage reduction of fungal growth was calculated with reference to the test colony diameter at the time when the corresponding control plate showed a full cover of fungus, i.e. when the control colony diameter was 90 mm. The results are shown in Table 1.

TABLE 1
__________________________________________________________________________
Final
%
colony
reduction
Taxonomic diameter
in Morphological
Casual
Group. Test Fungus (mm) growth
effects agent of:
__________________________________________________________________________
Phycomycetes
Phytophthora capsici
90.0 0% None Capsicum rot
Pythium ultimum
90.0 0% None Damping-off
Zygomycetes
Absidia glauca
51.0 43% Swelling & lysis*
Non-pathogen
Ascomycetes
Sordaria fimicola
56.5 37% Swelling*
Non-pathogen
Imperfecti
Alternaria brassicae
35.0 61% Swelling & lysis*
Leaf spot of brassicas
Botrytis cinerea
46.5 48% " Grey mould etc
Botrytis fabae
49.0 46% " Chocolate spot of bean
Fusarium oxysporum
76.0 0% " Vascular wilts
Monilinia fructigena
67.0 26% " Brown rot apple
Penicillium chrysogenum
57.0 37% " Non-pathogen
Phialophora radicola
35.5 61% " Non-pathogen
Leptospaeria muculans
27.5 64% " Oilseed rape canker
Rhizoctonia solani
51.0 43% " Damping-off
Monilinia laxa
43.5 52% " Brown rot apple
Trichodernam harzianum
57.5 36% " Non-pathogen
__________________________________________________________________________
*Fungi probably dead.

In similar tests activity of B. subtilis strain JB 3.6 was also demonstrated against the following fungi:

Botrytis allii

Botrytis elliptica

Botrytis narcissicola

Botrytis tulipae

Ascochtya fabae

Cladosporium herbarum

Saccharomyces cerevisiae

Candida albicans

PAC In vitro anti-bacterial bioassays

Nutrient agar plates were seeded with the test bacteria and streaked with B. subtilis strain JB 3.6. Plates were incubated at 30°C for 24h and the presence or absence of zones of inhibition around the B. subtilis streak was recorded.

B. subtilis produced zones of inhibitions when tested against the following bacteria:

Staphylococcus aureus

Streptococcus lactis

Strepococcus agalactiae

Micrococcus luteus

Micrococcus roseus

Bacillus megaterium

PAC Biological control of chocolate spot (Botrytis fabae) on faba bean by Bacillus subtilis (JB 3.6)

Four replicate plots (1 x 2 m) were used for each treatment with 1 m guard rows. The following treatments were used.

A. Plants inoculated by spraying with mixed isolate spore suspension of Botrytis fabae (105 spores ml-1) in nutrient solution on day 0 - i.e. control.

B. Plants inoculated with Botrytis fabae and a suspension of Bacillus subtilis cells (JB 3.6) (18h culture) on day 0.

C. Plants inoculated as B, followed by a repeat spray of B. subtilis cells (18h culture) on day 7.

D. Plants inoculated with Botrytis fabae and a suspension of B. subtilis cells (72h culture) on day 0.

E. Plants inoculated as D, followed by a repeat spray of B. subtilis cells (72h culture on day 7).

The experiment was designed as a randomized block. Prior to inoculation 5 plants were randomly selected from within each treatment block and tagged. Disease assessments were made on these plants by estimating the area of leaf which had turned brown/black on leaves 3-5. Mean values of % disease were then calculated. This procedure was considered more accurate than attempting to assign a somewhat subjective score for the whole plot. Results obtained as given in Table 2.

These results show that a significant level of control was achieved by 2d and maintained for the 14d duration of the experiment using 18h- or 72h culture of B. subtilis. Recording ceased after 14d as many control plot leaves had reached 100% disease and abscised. However observations made after this period indicated no further disease development on plots treated with B. subtilis for several weeks. By 4d the 72h bacterial culture gave more effective control than the 18h culture which permitted limited infection to occur before antibiotic production occurred. Microscopic examination of inoculated tissues indicated typical distortion of fungal germ tubes. A second spray with B. subtilis at 7d caused no significant improvement in control, possibly reflecting the death of the pathogen before this stage.

TABLE 2
__________________________________________________________________________
Disease development on faba bean following inoculation with
Botrytis fabae in presence and absence of Bacillus subtilis strain JB
3.6
Disease score (DS) and % disease reduction (% R)
Day 2 Day 4 Day 7 Day 10 Day 14
DS % R
DS % R
DS % R
DS % R
DS % R
__________________________________________________________________________
A 18.9
-- 40.7
-- 59.0
-- 66.7
-- 70.3
--
B 2.2a
88.4
7.9a
80.6
17.7a
70 18.9a
71.7
19.6a
72.1
C 1.6a
91.5
7.8a
80.8
13.9a
76.4
17.6a
73.6
18.3a
74.0
D 0.5a
97.4
1.4ab
96.6
5.0ab
91.5
6.7ab
90.0
71.1ab
89.9
E 0.2a
98.9
1.4ab
96.6
2.7ab
95.4
4.9ab
92.7
5.3ab
92.5
__________________________________________________________________________
a = significantly less than control (p = 0.001) by student `t` test
(mean of 60 replicates)
b = significantly less than treatments B and C (p = 0.001) by studen
`t` test

The efficacy of B. subtilis 3.6 in the control of Botrytis infection of bean in a polythene tunnel was further tested as follows. An overhead mist-irrigation system was installed to provide an environment highly suited to disease development, and a dwarf bean variety was used to reduce problems of lodging, which can occur in polytunnels. Four replicate plots were used for each treatment and the timing of application of the biocontrol agent was tested. B. subtilis 3.6 was applied to plots 3d before, simultaneous with and 7d after the application of Botrytis fabae spore suspension. By 7d the disease was beginning to develop symptoms. A further treatment used the rifampicin resistant strain of B. subtilis R1 (see Example 7) to monitor bacterial survival. Data for biological control are given in the accompanying drawing, which is a graph of percentage infection against time after inoculation. Mean disease scores represent the area of the fourth leaf infected in 10 randomly selected plants in each of the 4 replicate plots. Excellent control was obtained when bacteria were applied prophylactically before and simultaneous with the patbogen. The control agent also possessed the ability to greatly reduce disease when applied after infection had begun. Control was maintained for the 36d period of the experiment, by which time many of the leaves in control plots had abscinded.

PAC Control of Cladosporium fulvum infection of tomato

Four-week-old tomato seedlings were inoculated with the leaf mould patbogen in the presence or absence of B. subtilis JB 3.6. Plants were sprayed with a Bacillus 72h culture, left to dry, then sprayed with a suspension of Cladosporium spores. After enclosure in clear polythene bags for 48h, the plants were maintained in the glasshouse for 3 weeks. The percentage leaf area infected was assessed for leaves 1-3 and data obtained are given in Table 3. It is clear that Bacillus has reduced infection even though the experiment was performed under conditions that are disadvantageous for biological control agents. For instance, the inoculation procedure for this Cladosporium involves repeated spraying of whole plants; the likelihood of wash-off of the control agent must therefore be considered. Moreover, due to the extreme hemibiotrophic nature of this fungus, disease symptoms take a long time to appear.

TABLE 3
______________________________________
The effect of B. subtilis JB 3.6 in development of
Cladosporium fulvum infection of tomato
Leaf Percentage leaf area infected 21d after inoculation a
number Control +Bs JB 3.6
______________________________________
1 26.8 5.7
2 5.9 2.1
3 0.4 0.1
______________________________________
a = Mean of 15 replicate plants
PAC Control of Ascochyta pisi infection of pea

Three-week-old pea plants were spray inoculated with the leaf-spotting pathogen Ascochyta pisi. Half the population received a simultaneous inoculation with a 72h culture of B. subtilis JB 3.6. After 10 days growth the percentage infection was estimated on leaves 1-5 and stems; the data obtained (Table 4) show a clear reduction in disease levels. Control was most dramatic on younger leaves and stems. The treated plants tended to be considerably larger, probably reflecting the almost total absence of stem lesions. Owing to the extreme inwetability of pea plants these findings are especially interesting.

TABLE 4
______________________________________
The effect of B. subtilis JB 3.6 on development of Ascochyta pisi
infection of pea
Leaf Percentage leaf area infected 10d after inoculationa
number Control +Bs JB 3.6
______________________________________
1 100.0 92.3
2 100.0 87.7
3 98.3 26.9
4 75.8 18.5
5 36.7 2.7
STEM 28.3 0.9
______________________________________
a = Mean of 36 replicate plants
PAC Control of Take-All of Wheat

Preliminary experiments on take-all of wheat caused by Gauemannomyces graminis have been undertaken. B. subtilis R1 (a rifampicin-resistant strain-derived from Bs 3.6) has been used for these experiments as this will permit future experiments on the survival of the antagonist in soil. Initial, small scale experiments on biological control coated wheat seeds with approximately 5×107 cfu/seed. Coated and untreated seeds were sown in compost amended with the Gauemannomyces grown on oat kernels. After incubation for 4 weeks the plants were destructively assessed for take-all infection of roots and stem bases. The results obtained are given in Table 5 which shows significant reduction in this difficult-to-control disease.

A rifampicin resistant strain was isolated by agar diffusion bioassays using Oxoid Multodiscs containing 5 μg rifampicin. A 1 ml aliquot of a 24 hour nutrient broth culture of B. subtilis JB 3.6 was spread onto a nutrient agar plate containing the Multodisc and allowed to dry. Single colonies growing in the zone of inhibition were selected. One of these strains was designated R1.

TABLE 5
______________________________________
The effect of seed application of B. subtilis R1 on development of
take-all of wheat
Percentage plants developing
Seed treatment stem lesionsa
______________________________________
Untreated 77.8
SDWb wash 66.7
1% methyl cellulose
77.8
2.5% methyl cellulose
50.0
BsR1 in SDW 16.7
BsR1 in 1% methyl cellulose
28.6
BsR1 in 2.5% methyl cellulose
14.3
______________________________________
a = Mean of 12 plants
b = Sterile distilled water
PAC Control of Peronospora infection of oilseed rape

Downy mildew infection caused by Peronospora is an example of a biotrophic fungal disease. As such in vitro bioassays against this pathogen cannot be done. Preliminary experiments have therefore been carried out to attempt to reduce incidence of disease on oilseed rape by application of B. subtilis JB 3.6. Cotyledons were sprayed with sporangia of Peronospora; a simultaneous application of 72h culture of Bacillus was made to half the population. Plants were incubated under clear plastic propagators for 5d when the percentage area of cotyledons infected was estimated. Disease levels were reduced to less than half the control by the antagonist. Peronospora on oilseed rape is a pathogen of minor importance. However, other downy mildews (e.g. grape vine) and the closely related pathogens Phytophthora and Pythium, which are difficult to control existing methods, cause serious economic losses.

PAC Control of Powdery mildew on cereals

Powdery mildews (Erysiphe graminis) on cereals probably represent the most economically damaging diseases of crop plants in Britain. Despite extensive plant breeding programmes and chemical control strategies these highly specialized pathogens still cause significant losses. Their biotrophic nature precludes in vitro bioassays. Glasshouse trials on control of mildew on wheat have been performed. Application of 72h cultures of B. subtilis JB 3.6 to wheat plants was given by three sprays immediately prior to inoculation with mildew. Plants were inspected 14 days after inoculation; the results (Table 6) show that application of B. subtilis significantly reduced disease symptoms on leaves.

TABLE 6
______________________________________
The effect of B. subtilis JB 3.6 on development of mildew
infection of wheat.
Leaf Percentage leaf area infected 14 d after inoculation
number Control + Bs JB 3.6
______________________________________
1 51.0 16.6
2 32.8 8.8
______________________________________

A problem with biological control of cereal diseases is that bacterial cultures fail to effectively wet cereal leaves and run-off of the control agent can occur. This can lead to problems with reproducibility of results. We have shown that these problems can be overcome by adding "sticker" compounds such as surfactants, to the bacterial culture. These compounds can prevent run-off of the control agent from the leaves. Results obtained using one such compound, Ethylan CD107, are shown in Table 7. In a glasshouse trial wheat plants were sprayed with 72h cultures of B. subtilis JB 3.6 immediately prior to inoculation with mildew. Some plants were sprayed with cultures containing 0.1% Ethylan CD107. Plants were inspected 10 days after inoculation; the results show that addition of Ethylan CD107 significantly improved disease control.

TABLE 7
__________________________________________________________________________
The effect of Ethylan CD107 on control of mildew infection of wheat by B.
subtilis JB 3.6.
Leaf Percentage leaf area infected 10 d after inoculation
number Control + BS JB 3.6
+ BS JB 3.6 + Ethylan CD107
__________________________________________________________________________
1 18.2 18.9 1.4
__________________________________________________________________________

Broadent P, Baker K. F, Waterworth Y. 1971 Bacteria and actinomycetes antagonistic to fungal root pathogens in Australian soils. Australian Journal of Biological Science, 24:925-944

Chang I P, Kommedahl T. 1968 Biological control of seedling blight of corn by coating kernals with antagonistic microorganisms. Phytopathology 58: 1395-1401

Olsen C M 1964 Antagonistic effects of microorganisms on Rhizoctonia solani in soil. PhD thesis, University of California Berkeley. 152 pp

Olsen C M, Baker K F, 1968 Selective heat treatment of soil, and its effect on the inhibition of Rhizoctonia solani by Bacillus subtilis Phytopathology 58:79-87

Swinburne T R 1973 Microflora of apple leaf scars in relation to infection by Nectria galligena. Transactions of the British Mycological Society 60:389-403

Rossall, Stephen

Patent Priority Assignee Title
10375964, Dec 29 2014 FMC Corporation Microbial compositions and methods of use for benefiting plant growth and treating plant disease
5614188, Oct 06 1993 Murakashi Lime Industry Co., Ltd. Anti-fusarium composition containing strains of bacillus Sp., a chitin-containing material, and a powdery material
6060051, May 09 1997 BAYER CROPSCIENCE LP Strain of bacillus for controlling plant diseases and corn rootworm
6103228, May 08 1998 BAYER CROPSCIENCE LP Compositions and methods for controlling plant pests
6239103, May 09 1997 AgraQuest, Inc. Strain of bacillus for controlling plant diseases and corn rootworm
6245551, Mar 30 1999 BAYER CROPSCIENCE LP Strain of Bacillus pumilus for controlling plant diseases caused by fungi
6291426, May 09 1997 BAYER CROPSCIENCE LP Strain of bacillus for controlling plant diseases and corn rootworm
6417163, May 09 1997 BAYER CROPSCIENCE LP Compositions and methods for controlling plant pests
6586231, Mar 30 1991 BAYER CROPSCIENCE LP Strain of bacillus for controlling plant diseases
6635245, Mar 30 1999 BAYER CROPSCIENCE LP Strain of bacillus for controlling plant diseases
6638910, May 09 1997 BAYER CROPSCIENCE LP Compositions and methods for controlling plant pests
6808917, Feb 02 2001 NOVOZYMES BIOAG A S Controlling plant pathogens with fungal/bacterial anatagonist combinations
7211428, May 18 2004 Council of Scientific & Industrial Research Strain of Bacillus as a bioinoculant
7294228, Feb 26 2003 YFY INC Biopulp for non-woody fiber plants and biopulping method thereof
7507402, Apr 10 1998 Ganeden Biotech, Incorporated Topical use of probiotic Bacillus spores to prevent or control microbial infections
8821854, Apr 18 1997 Ganeden Biotech, Inc. Methods for inhibiting microbial infections associated with sanitary products and for enhancing sanitary product degradation
9017442, Apr 20 2012 NOVOZYMES BIOAG A S Use of synergistic microorganisms and nutrients to produce signals that facilitate the germination and plant root colonization of mycorrhizal fungi in phosphorus rich environments
9416061, Apr 20 2012 NOVOZYMES BIOAG A/S Use of synergistic microorganisms and nutrients to produce signals that facilitate the germination and plant root colonization of mycorrhizal fungi in phosphorus rich environments
9622484, Dec 29 2014 FMC Corporation Microbial compositions and methods of use for benefiting plant growth and treating plant disease
Patent Priority Assignee Title
4181714, Mar 11 1977 Kikagaku Kenkyusho; Ajinomoto Antibiotics Bacileucines A and B and process for production and use thereof
4582704, Oct 07 1983 The United States of America as represented by the Secretary of Control of bean rust with Bacillus subtilis
4764371, May 01 1984 The United States of America as represented by the Secretary of Postharvest biological control of stone fruit brown rot by bacillus subtilis
5061495, Mar 07 1988 Agricultural Genetics Company Limited Antibiotic derived from B. subtilis
CH446615,
DE2806813,
FR2508766,
GB2061284,
GB2200924,
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 29 1992Agricultural Genetics Company Limited(assignment on the face of the patent)
Sep 30 1994ROMANOWSKI, JOHN C A TWENTY PERCENT INTEREST TO THE ACADEMY OF APPLIED SCIENCEASSIGN 20% INTEREST0071750223 pdf
Date Maintenance Fee Events
Feb 23 1998M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Feb 07 2002M184: Payment of Maintenance Fee, 8th Year, Large Entity.
Feb 13 2006M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Sep 06 19974 years fee payment window open
Mar 06 19986 months grace period start (w surcharge)
Sep 06 1998patent expiry (for year 4)
Sep 06 20002 years to revive unintentionally abandoned end. (for year 4)
Sep 06 20018 years fee payment window open
Mar 06 20026 months grace period start (w surcharge)
Sep 06 2002patent expiry (for year 8)
Sep 06 20042 years to revive unintentionally abandoned end. (for year 8)
Sep 06 200512 years fee payment window open
Mar 06 20066 months grace period start (w surcharge)
Sep 06 2006patent expiry (for year 12)
Sep 06 20082 years to revive unintentionally abandoned end. (for year 12)